Subcutaneous NAD+ injections have the better-established absorption of the two routes; transdermal patches are needle-free and more convenient, but the evidence that NAD+ crosses intact skin in meaningful amounts is limited. If your priority is a measured, biomarker-backed protocol, injection is the more defensible route. If needles are a dealbreaker, a patch is a reasonable starting point — provided you treat its delivery as less certain and track whether it actually moves your numbers.
This is a route-of-delivery question, not a question about NAD+ itself. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, central to mitochondrial energy production and DNA repair, and its levels decline with age (NAD+ in Aging review, PMC7494058). The open question is how to get it into your system reliably.
How does NAD+ injection delivery work?
A subcutaneous NAD+ injection deposits the compound into the fatty tissue under the skin, where it absorbs gradually and bypasses the digestive tract entirely. Typical at-home doses are 50–100 mg, one to three times weekly, often titrated up by ~20 mg every one to two weeks (Empower Pharmacy; MediveraRx).
Parenteral (injected) administration is described by compounding-pharmacy literature as the most effective way to raise NAD+ levels, because it avoids the first-pass metabolism that breaks down oral forms (MediveraRx). The tradeoff is the needle and the rate-sensitivity: pushing a dose too quickly can cause flushing or nausea, which is why slow subcutaneous delivery is generally more comfortable than rapid IV infusion (Perfect B).
How do NAD+ patches work — and is the absorption proven?
A transdermal NAD+ patch is designed to release the compound through the skin over several hours. The appeal is real: needle-free, discreet, apply-and-forget. The biology, however, is where caution is warranted.
NAD+ is a large, charged, water-loving molecule with a molecular weight of roughly 663 daltons. Transdermal drug delivery generally works best for molecules under about 500 daltons that are lipid-soluble; large polar molecules like NAD+ do not readily cross the intact stratum corneum without penetration enhancers (Bolt Pharmacy review; transdermal delivery review, PMC11703487). As of 2026, there are no published randomized trials comparing NAD+ patches to placebo in humans, and no pharmacokinetic studies measuring blood NAD+ after patch use (Bolt Pharmacy).
That does not make patches useless — some users report benefit, and formulation science continues to improve — but it does mean the honest framing is “convenient, with less-established absorption,” not “equivalent to injection.”
NAD+ patch vs. injection: side-by-side
| Injection (subcutaneous) | Patch (transdermal) | |
|---|---|---|
| Absorption evidence | Established; bypasses the gut | Limited; no published human PK data |
| Molecule barrier | None — deposited under skin | NAD+ (~663 Da, charged) resists skin penetration |
| Convenience | ~2 min, self-administered | Needle-free, apply for hours |
| Comfort | Mild flushing/nausea if rushed | No needle; possible skin irritation |
| Best for | Measured, biomarker-tracked protocols | Needle-averse users prioritizing convenience |
Who should choose which?
Choose injection if you want the most established route and you intend to verify results with baseline and follow-up labs. Choose a patch if needles are a genuine barrier to starting at all — a convenient route you’ll actually use beats a precise one you avoid. The most common patch candidate is a needle-fatigued injection user looking for a steadier, travel-friendly option.
Whichever you pick, the discipline that matters most is the same: anchor on a baseline measurement, then re-test, so the route is judged on whether your biomarkers move — not on how the dose felt going in.
A note on honesty: NAD+ is prescribed and compounded by a state-licensed, FDA-regulated compounding pharmacy. Compounded medications are not FDA-approved as finished products, and definitive efficacy trials for both routes are still limited. A clinician should review your full health context before any protocol.
NAD+ patch vs. injection FAQ
Are NAD+ patches as effective as injections? The evidence does not currently support an equivalence claim. Injections have established bioavailability; transdermal NAD+ absorption is biophysically limited and lacks published human pharmacokinetic data. Patches are best framed as a convenient, less-proven option.
Why can’t NAD+ just be absorbed through the skin easily? NAD+ is a large (~663 Da), charged, water-soluble molecule. The skin’s outer layer blocks most molecules above ~500 daltons unless penetration enhancers are used, which makes reliable transdermal delivery difficult.
Why not just take an NAD+ pill instead? Oral NAD+ and its precursors face heavy first-pass metabolism, so much of the dose is broken down before reaching cells. Injection avoids this entirely, which is why parenteral routes are described as the most effective way to raise NAD+.
Do NAD+ injections hurt? Subcutaneous injections use a small insulin-type needle and are generally well tolerated. The most common complaints are mild flushing or nausea, usually tied to injecting too quickly and managed by slowing the rate.
How will I know if my route is working? The reliable answer is measurement: a baseline panel before starting and a re-test (commonly at 90 days), so you can see whether specific biomarkers move rather than relying on how you feel.
Considering NAD+? A clinician-guided assessment can help you choose the route that fits your goals and health context. Start your free Vitality Assessment →